CN101525291A - Green asymmetric synthesis method of chiral bicyclics compound - Google Patents

Green asymmetric synthesis method of chiral bicyclics compound Download PDF

Info

Publication number
CN101525291A
CN101525291A CN 200910097515 CN200910097515A CN101525291A CN 101525291 A CN101525291 A CN 101525291A CN 200910097515 CN200910097515 CN 200910097515 CN 200910097515 A CN200910097515 A CN 200910097515A CN 101525291 A CN101525291 A CN 101525291A
Authority
CN
China
Prior art keywords
phenyl
acid
formula
chiral
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200910097515
Other languages
Chinese (zh)
Other versions
CN101525291B (en
Inventor
许丹倩
夏爱宝
罗书平
徐振元
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang University of Technology ZJUT
Original Assignee
Zhejiang University of Technology ZJUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang University of Technology ZJUT filed Critical Zhejiang University of Technology ZJUT
Priority to CN 200910097515 priority Critical patent/CN101525291B/en
Publication of CN101525291A publication Critical patent/CN101525291A/en
Application granted granted Critical
Publication of CN101525291B publication Critical patent/CN101525291B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a green asymmetric synthesis method of chiral bicyclics compound as shown in formula (I): taking cyclohexene ketone derivative as shown in formula (II) and nitroolefin derivative as shown in formula (III) as raw materials; in the existence of chiral secondary amine catalyst, protonic acid and water, reacting for 3-72 hours at a temperature of -20-40 DEG C; after the completion of the reaction, processing the obtained reaction liquid to obtain the chiral bicyclics compound as shown in the formula (I); the chiral secondary amine catalyst is the praline derivative as shown in formula (IV); quantity relative ratio of the nitroolefin derivative as shown in formula (III) to the cyclohexene ketone derivative as shown in formula (II) is 1:1-3. The chiral bicyclics compound provided in the invention is a new chiral compound, the synthesized compound synthesized by aqueous phase in a green way demonstrates fine reactive characteristics, thus being capable of being used in the field of organic synthesis, material and the like.

Description

A kind of green method of asymmetric synthesis of chiral bicyclics compound
(1) technical field
The present invention relates to a kind of green method of asymmetric synthesis of chiral bicyclics compound.
(2) background technology
Asymmetric synthesis has become the important research direction of 21 century chemistry, is an indispensable integral part in fields such as Synthetic Organic Chemistry, biological chemistry, medical chemistry and chemistry of pesticide.Usually, asymmetric catalysis synthesis is realized by using chiral auxiliary(reagent), chiral reagent and chiral catalyst.The catalysis asymmetric synthesis is optimal method of asymmetric synthesis, and it only uses a spot of chiral catalyst just to obtain a large amount of chiral product.
Chiral bicyclics compound is the very important compound of a class, is the precursor of a lot of medicines and a very important class synthetic intermediate.Wherein, the catalytic Diels-Alder reaction of chirality secondary amine is the important reaction of synthesis of chiral bicyclics compound one class.MacMillan group in 2000 utilization catalyzer (1) reacts (J.Am.Chem.Soc., 2000,122,4243) by the Diels-Alder of imines catalytic olefine and diene first, synthesized the chiral bicyclics compound that a class contains aldehyde radical.Barbas group utilizes the Diels-Alder reaction (Terahedron Lett., 2002,43,3817) of catalyzer (2) by enamine catalysis ketenes and nitroolefin first.C ó rdova group utilizes the Diels-Alder reaction of catalyzer (2) catalysis cyclonene and nitroolefin first, synthesized the chiral bicyclics compound that a class contains nitro.Through reaction in four days, the yield of product reached 61%, and diastereomer ratio is>25: 1, and ee value (enantiomeric excess value) can reach 67% (Adv.Synth.Catal., 2007,349,2549).
Figure A20091009751500061
Water is synthetic except the cost cheapness, and outside the factors such as environmental friendliness, water react can have good promoter action to the reactive behavior and the selectivity of substrate.Recently, the Asymmetric Diels-Alder Reaction research of carrying out at aqueous phase also has report.Ogilvie group is by self-designed catalyzer (3), and in the Diels-Alder of aqueous phase success catalytic olefine and diene reaction, the yield that reaction finishes after product reaches 88%, ee value (enantiomeric excess value) can reach 94% (Org.Lett., 2005,7,4141).The Diels-Alder of Hayashi group utilization catalyzer (4) catalytic olefine and diene reacts, and finds to have promoted at aqueous phase the carrying out of this reaction, and speed and the optical selective that reacts all had good promoter action.Yield through 11 hours reaction after products reaches 93%, and ee value (enantiomeric excess value) can reach 94% (Angew.Chem.Int.Ed., 2008,47,6634).
These achievements in research have been enriched the kind of aqueous phase Diels-Alder reaction, for green synthesis of chiral bicyclics compound provides multiple synthetic method.But, the research work in this field just just begins, further explore new catalyzer and reaction type, synthetic new chiral bicyclics compound, and then research and develop it in Application for Field such as asymmetric organic synthesis and medicines, and final obtain to have good asymmetric induction effect, be easy to the reaction system that recovery set such as uses at characteristic, will be important emerging research field in the modern Green Chemistry.
(3) summary of the invention
The object of the present invention is to provide a kind of green method of asymmetric synthesis of chiral bicyclics compound.
The technical solution used in the present invention is:
A kind of green method of asymmetric synthesis suc as formula the chiral bicyclics compound shown in (I), described method is: being raw material suc as formula the cyclohexenone derivates shown in (II) with suc as formula the nitroolefin derivative shown in (III), in the presence of chirality secondary amine catalyst, protonic acid and water, under-20~40 ℃ of temperature, reacted 3~72 hours, after reaction finished, the reaction solution separating treatment obtained suc as formula the chiral bicyclics compound shown in (I); Described chirality secondary amine catalyst is suc as formula the proline derivative shown in (IV); Described is 1: 1~3 suc as formula the nitroolefin derivative shown in (III) with suc as formula the amount of substance ratio of the cyclohexenone derivates shown in (II); Described amount of substance ratio suc as formula the nitroolefin derivative shown in (III), chirality secondary amine catalyst, protonic acid, water is 1: 0.05~0.3: 0.05~0.3: 30~40;
Figure A20091009751500071
In formula (I), formula (II), formula (III) or the formula (IV), R 1, R 2, R 3Independent separately is the alkyl of H or C1~C20; R 4Be H, the alkyl of C1~C20, the 2-p-methoxy-phenyl, the 3-p-methoxy-phenyl, the 4-p-methoxy-phenyl, the 2-aminomethyl phenyl, the 3-aminomethyl phenyl, the 4-aminomethyl phenyl, phenyl, the fluorine-based phenyl of 2-, the fluorine-based phenyl of 3-, the fluorine-based phenyl of 4-, 2-chloro phenyl, 3-chloro phenyl, 4-chloro phenyl, 2-bromo phenyl, 3-bromo phenyl, 4-bromo phenyl, the 2-nitrophenyl, the 3-nitrophenyl, the 4-nitrophenyl, the 2-trifluoromethyl, the 3-trifluoromethyl, the 4-trifluoromethyl, furyl or thienyl; R 5Be one of following formula:
Figure A20091009751500081
Reaction equation is as follows:
Figure A20091009751500082
Comparatively preferred, in formula (I), formula (II), formula (III) or the formula (IV), described R 1, R 2, R 3Independent separately is hydrogen or methyl; Described R 4Be preferably 2-p-methoxy-phenyl, 3-p-methoxy-phenyl, 4-p-methoxy-phenyl, 4-aminomethyl phenyl, phenyl, the fluorine-based phenyl of 4-, 4-chloro phenyl, 3-bromo phenyl, 4-bromo phenyl, 3-nitrophenyl, 4-trifluoromethyl or furyl; Described R 5Be preferably following formula:
More specifically, described chiral bicyclics compound is: (1) (1S, 4S, 5S, 6R) 6-(2-p-methoxy-phenyl)-5-nitro two rings [2,2,2] octane-2-ketone, (2) (1S, 4S, 5S, 6R) 6-(3-p-methoxy-phenyl)-5-nitro two ring [2,2,2] octane-2-ketone, (3) (1S, 4S, 5S, 6R) 6-(4-p-methoxy-phenyl)-5-nitro two rings [2,2,2] octane-2-ketone, (4) (1S, 4S, 5S, 6R) 6-(4-aminomethyl phenyl)-5-nitro two rings [2,2,2] octane-2-ketone, (5) (1S, 4S, 5S, 6R) 6-phenyl-5-nitro two ring [2,2,2] octane-2-ketone, (6) (1S, 4S, 5S, 6R) 6-(the fluorine-based phenyl of 4-)-5-nitro two rings [2,2,2] octane-2-ketone, (7) (1S, 4S, 5S, 6R) 6-(4-chloro phenyl)-5-nitro two rings [2,2,2] octane-2-ketone, (8) (1S, 4S, 5S, 6R) 6-(3-bromo phenyl)-5-nitro two rings [2,2,2] octane-2-ketone, (9) (1S, 4S, 5S, 6R) 6-(4-bromo phenyl)-5-nitro two ring [2,2,2] octane-2-ketone, (10) (1S, 4S, 5S, 6R) 6-(3-nitrophenyl)-5-nitro two rings [2,2,2] octane-2-ketone, (11) (1S, 4S, 5S, 6R) 6-(4-trifluoromethyl)-5-nitro two rings [2,2,2] octane-2-ketone, (12) (1S, 4S, 5S, 6R) 6-furans-5-nitro two rings [2,2,2] octane-2-ketone, (13) (1S, 4S, 5S, 6R) 6-phenyl-4-methyl-5-nitro two ring [2,2,2] octane-2-ketone, (14) (1S, 2R, 3S, 4R) 2-phenyl-5,5-dimethyl-3-nitro two rings [2,2,2] octane-7-ketone.
Described is 1: 1~3 suc as formula the nitroolefin derivative shown in (III) with suc as formula the amount of substance ratio of the cyclohexenone derivates shown in (II), is preferably 1: 1.2.
Described chirality secondary amine catalyst is a proline derivative, and its general structure is formula (IV), preferably shown in formula V;
Figure A20091009751500091
It is one of following that the present invention recommends described protonic acid: HCl, HBr, H 2SO 4, HBF 4, HPF 6, CH3COOH, CF 3COOH, CF 3SO 3H, phenylformic acid, o-fluorobenzoic acid, a fluorobenzoic acid, parafluorobenzoic acid, toluylic acid, p-methylbenzoic acid, o-Carboxynitrobenzene, M-NITROBENZOIC ACID, p-nitrobenzoic acid, o-trifluoromethyl phenylformic acid, m-trifluoromethylbenzoic acid, to trifluoromethylbenzoic acid, Phenylsulfonic acid, p-methyl benzenesulfonic acid, to Witco 1298 Soft Acid, α-Nai Huangsuan, beta-naphthalenesulfonic-acid, α-Nai Yisuan, oleic acid, stearic acid, dodecyl sulfonic acid or methacrylic acid.
The preferred described protonic acid of the present invention is organic protonic acid, and it is one of following that described organic protonic acid is preferably: phenylformic acid, parafluorobenzoic acid, p-nitrobenzoic acid, o-trifluoromethyl phenylformic acid or to trifluoromethylbenzoic acid; Most preferably be trifluoromethylbenzoic acid, structure is suc as formula shown in (VI):
Figure A20091009751500101
Described amount of substance ratio suc as formula the nitroolefin derivative shown in (III), chirality secondary amine catalyst, protonic acid, water is 1: 0.05~0.3: 0.05~0.3: 30~40, is preferably 1: 0.2: 0.2: 34.
Described temperature of reaction is 15~40 ℃, is preferably 25 ℃; The described reaction times is 3~72 hours, is preferably 12~36 hours.
Reaction solution method for separating and processing of the present invention is: after reaction finishes, the reaction solution ethyl acetate extraction, standing demix, get the organic layer distillation except that the residuum after desolvating, with the volume ratio of sherwood oil and ether is that 7: 3 elutriant is an eluent, carries out column chromatography for separation and purifies and obtain the chiral bicyclics compound product.
Comparatively concrete, recommend the green method of asymmetric synthesis of chiral bicyclics compound of the present invention to carry out: being raw material suc as formula the cyclohexenone derivates shown in (II) with suc as formula the nitroolefin derivative shown in (III) according to following steps, in the chirality secondary amine catalyst shown in formula V, under the existence shown in (VI) to trifluoromethylbenzoic acid and water, under 25 ℃ of temperature, reacted 12~36 hours, after reaction finishes, the reaction solution ethyl acetate extraction, standing demix, getting the residuum that organic layer distillation removes after desolvating is that 7: 3 elutriant is an eluent with the volume ratio of sherwood oil and ether, carries out column chromatography for separation and purifies and obtain the chiral bicyclics compound product; In described formula (II) or the formula (III), R 1, R 2, R 3Independent separately is hydrogen or methyl; R 4Be 2-p-methoxy-phenyl, 3-p-methoxy-phenyl, 4-p-methoxy-phenyl, 4-aminomethyl phenyl, phenyl, the fluorine-based phenyl of 4-, 4-chloro phenyl, 3-bromo phenyl, 4-bromo phenyl, 3-nitrophenyl, 4-trifluoromethyl or furyl; Described is 1: 1.2 suc as formula the nitroolefin derivative shown in (III) with suc as formula the amount of substance ratio of the cyclohexenone derivates shown in (II); Described is 1: 0.2: 0.2 suc as formula the nitroolefin derivative shown in (III), chirality secondary amine catalyst, to the amount of substance ratio of trifluoromethylbenzoic acid, water: 34.
The present invention compared with prior art, its beneficial effect is: chiral bicyclics compound of the present invention has chirality; Green synthetic this compounds of water shows good response characteristic, can be applied to fields such as organic synthesis, material.
(4) embodiment
The present invention is described further below in conjunction with specific embodiment, but protection scope of the present invention is not limited in this.
Comprise in the specific embodiments of the invention:
(1S, 4S, 5S, 6R) 6-(2-p-methoxy-phenyl)-5-nitro two ring [2,2,2] octane-2-ketone;
(1S, 4S, 5S, 6R) 6-(3-p-methoxy-phenyl)-5-nitro two ring [2,2,2] octane-2-ketone;
(1S, 4S, 5S, 6R) 6-(4-p-methoxy-phenyl)-5-nitro two ring [2,2,2] octane-2-ketone;
(1S, 4S, 5S, 6R) 6-(4-aminomethyl phenyl)-5-nitro two ring [2,2,2] octane-2-ketone;
(1S, 4S, 5S, 6R) 6-phenyl-5-nitro two ring [2,2,2] octane-2-ketone;
(1S, 4S, 5S, 6R) 6-(the fluorine-based phenyl of 4-)-5-nitro two ring [2,2,2] octane-2-ketone;
(1S, 4S, 5S, 6R) 6-(4-chloro phenyl)-5-nitro two ring [2,2,2] octane-2-ketone;
(1S, 4S, 5S, 6R) 6-(3-bromo phenyl)-5-nitro two ring [2,2,2] octane-2-ketone;
(1S, 4S, 5S, 6R) 6-(4-bromo phenyl)-5-nitro two ring [2,2,2] octane-2-ketone;
(1S, 4S, 5S, 6R) 6-(3-nitrophenyl)-5-nitro two ring [2,2,2] octane-2-ketone;
(1S, 4S, 5S, 6R) 6-(4-trifluoromethyl)-5-nitro two ring [2,2,2] octane-2-ketone;
(1S, 4S, 5S, 6R) 6-furans-5-nitro two ring [2,2,2] octane-2-ketone;
(1S, 4S, 5S, 6R) 6-phenyl-4-methyl-5-nitro two ring [2,2,2] octane-2-ketone;
(1S, 2R, 3S, 4R) 2-phenyl-5,5-dimethyl-3-nitro two ring [2,2,2] octane-7-ketones;
Embodiment 1:(1S, 4S, 5S, 6R) 6-(2-p-methoxy-phenyl)-5-nitro two ring [2,2,2] octane-2-ketone
25mL in vitro adds 2-p-methoxy-phenyl nitroolefin (0.134g, 0.75mmol), cyclonene (0.096g, 1mmol) with 0.5mL water, at chirality secondary amine catalyst (V) (0.029g, 0.15mmol) and to trifluoromethylbenzoic acid (VI) (0.0285g, 0.15mmol) common catalysis following 25 ℃ the reaction 20h, with ethyl acetate extraction (2 * 20mL), standing demix is got after organic layer distillation takes off most solvent, and residuum is that 7: 3 elutriant is an eluent with the volume ratio of sherwood oil and ether, carry out the column chromatography for separation purification and obtain target compound (0.124g, yield 60%, Ee value are 90%), wherein 1H NMR (500MHz, CDCl3): δ=7.25-7.23 (m, 1H), 7.16-7.14 (m, 1H), 6.90-6.88 (m, 1H), 6.86-6.84 (m, 1H), 4.96-4.94 (m, 1H), 4.19-4.18 (m, 1H), 3.7 (s, 3H), 2.87-2.85 (m, 1H), 2.71-2.70 (m, 1H), 2.42-2.41 (m, 2H), 2.31-2.24 (m, 1H), 1.99-1.88 (m, 2H), 1.68-1.61 (m, 1H) ppm; 13C NMR (125MHz, CDCl3): δ=212.1,156.7,128.9 (* 2), 128.0,120.8,110.7,90.0,54.4,46.1,42.1,41.9,34.8,24.0,18.6ppm.
Embodiment 2:(1S, 4S, 5S, 6R) preparation of 6-(3-p-methoxy-phenyl)-5-nitro two ring [2,2,2] octane-2-ketone
25mL in vitro adds 3-p-methoxy-phenyl nitroolefin (0.134g, 0.75mmol), cyclonene (0.096g, 1mmol) with 0.5mL water, at chirality secondary amine catalyst (V) (0.029g, 0.15mmol) and to trifluoromethylbenzoic acid (VI) (0.0285g, 0.15mmol) common catalysis following 25 ℃ the reaction 12h, with ethyl acetate extraction (2 * 20mL), standing demix is got after organic layer distillation takes off most solvent, and residuum is that 7: 3 elutriant is an eluent with the volume ratio of sherwood oil and ether, carry out the column chromatography for separation purification and obtain target compound (0.165g, yield 80%, Ee value are 96%), wherein 1H NMR (500MHz, CDCl3): δ=7.24-7.21 (m, 1H), 6.80-6.78 (m, 1H), 6.67-6.65 (s, 2H), 4.82-4.80 (m, 1H), 4.13-4.11 (m, 1H), 3.77 (s, 3H), 2.97-2.95 (m, 1H), 2.69-2.68 (m, 1H), 2.50-2.48 (m, 2H), 2.24-2.18 (m, 1H), 1.97-1.90 (m, 2H), 1.73-1.68 (m, 1H) ppm; 13C NMR (125MHz, CDCl3): δ=211.7,160.0,142.6,130.3,118.8,112.9,112.8,91.1,55.2,47.4,44.9,42.2,34.3,23.3,18.2ppm.
Embodiment 3:(1S, 4S, 5S, 6R) preparation of 6-(4-p-methoxy-phenyl)-5-nitro two ring [2,2,2] octane-2-ketone
25mL in vitro adds 4-p-methoxy-phenyl nitroolefin (0.134g, 0.75mmol), cyclonene (0.096g, 1mmol) with 0.5mL water, at chirality secondary amine catalyst (V) (0.029g, 0.15mmol) and to trifluoromethylbenzoic acid (VI) (0.0285g, 0.15mmol) common catalysis following 25 ℃ the reaction 20h, with ethyl acetate extraction (2 * 20mL), standing demix is got after organic layer distillation takes off most solvent, and residuum is that 7: 3 elutriant is an eluent with the volume ratio of sherwood oil and ether, carry out the column chromatography for separation purification and obtain target compound (0.202g, yield 98%, Ee value are 93%), wherein 1H NMR (500MHz, CDCl3): δ=7.02-7.00 (d, J=10Hz, 2H), 6.84-6.82 (d, J=10Hz, 2H), 4.78-4.77 (d, J=5Hz, 1H), 4.08-4.07 (d, J=5Hz, 1H), 3.76 (s, 3H), 2.94 (s, 1H), 2.63 (s, 1H), 2.52-2.44 (m, 2H), 2.22-2.17 (m, 1H), 1.95-1.90 (m, 2H), 1.71-1.66 (m, 1H) ppm; 13C NMR (125MHz, CDCl3): δ=211.9,158.8,133.1,127.9 (* 2), 114.4 (* 2), 91.4,55.2,47.8,44.2,42.2,34.2,23.2,18.1ppm.
Embodiment 4:(1S, 4S, 5S, 6R) preparation of 6-(4-aminomethyl phenyl)-5-nitro two ring [2,2,2] octane-2-ketone
25mL in vitro adds 4-aminomethyl phenyl nitroolefin (0.122g, 0.75mmol), cyclonene (0.096g, 1mmol) with 0.5mL water, at chirality secondary amine catalyst (V) (0.029g, 0.15mmol) and to trifluoromethylbenzoic acid (VI) (0.0285g, 0.15mmol) common catalysis following 25 ℃ the reaction 20h, with ethyl acetate extraction (2 * 20mL), standing demix is got after organic layer distillation takes off most solvent, and residuum is that 7: 3 elutriant is an eluent with the volume ratio of sherwood oil and ether, carry out the column chromatography for separation purification and obtain target compound (0.188g, yield 97%, Ee value are 93%), wherein 1H NMR (500MHz, CDCl3): δ=7.12-7.10 (d, J=10Hz, 2H), 6.99-6.97 (d, J=10Hz, 2H), 4.81-4.79 (m, 1H), 4.11-4.09 (m, 1H), 2.96-2.94 (m, 1H), 2.65-2.64 (m, 1H), 2.53-2.44 (m, 2H), 2.30 (s, 3H), 2.24-2.17 (m, 1H), 1.97-1.89 (m, 2H), 1.72-1.67 (m, 1H) ppm; 13CNMR (125MHz, CDCl3): δ=211.9,138.1,137.4,129.8 (* 2), 126.7 (* 2), 91.3,47.8,44.7,42.3,34.4,23.3,20.9,18.2ppm.
Embodiment 5:(1S, 4S, 5S, 6R) preparation of 6-phenyl-5-nitro two ring [2,2,2] octane-2-ketone
25mL in vitro adds phenyl nitroolefin (0.112g, 0.75mmol), cyclonene (0.096g, 1mmol) with 0.5mL water, at chirality secondary amine catalyst (V) (0.029g, 0.15mmol) and to trifluoromethylbenzoic acid (VI) (0.0285g, 0.15mmol) common catalysis following 25 ℃ the reaction 20h, with ethyl acetate extraction (2 * 20mL), standing demix is got after organic layer distillation takes off most solvent, and residuum is that 7: 3 elutriant is an eluent with the volume ratio of sherwood oil and ether, carry out the column chromatography for separation purification and obtain target compound (0.180g, yield 98%, Ee value are 95%), wherein 1H NMR (500MHz, CDCl3): δ=7.33-7.24 (m, 3H), 7.11-7.09 (d, J=10Hz, 2H), 4.83-4.81 (m, 1H), 4.16-4.15 (m, 1H), 2.98-2.96 (m, 1H), 2.69-2.68 (m, 1H), 2.55-2.45 (m, 2H), 2.26-2.19 (m, 1H), 1.99-1.90 (m, 2H), 1.74-1.68 (m, 1H) ppm; 13C NMR (125MHz, CDCl3): δ=211.8,141.1,129.2 (* 2), 127.7,126.8 (* 2), 91.2,47.6,45.0,42.3,34.4,23.4,18.3ppm.
Embodiment 6:(1S, 4S, 5S, 6R) preparation of 6-phenyl-5-nitro two ring [2,2,2] octane-2-ketone
25mL in vitro add the phenyl nitroolefin (0.112g, 0.75mmol), cyclonene (0.096g, 1mmol) and 0.5mL water, in the chirality secondary amine catalyst
Figure A20091009751500141
(0.029g, 0.15mmol) and phenylformic acid (0.0285g, 0.15mmol) common catalysis following 25 ℃ the reaction 24h, (2 * 20mL), standing demix is got after organic layer distillation takes off most solvent with ethyl acetate extraction, residuum is that 7: 3 elutriant is an eluent with the volume ratio of sherwood oil and ether, carry out the column chromatography for separation purification and obtain target compound (the Ee value is 82% for 0.165g, yield 90%).
Embodiment 7:(1S, 4S, 5S, 6R) preparation of 6-phenyl-5-nitro two ring [2,2,2] octane-2-ketone
25mL in vitro add the phenyl nitroolefin (0.112g, 0.75mmol), cyclonene (0.072g, 0.75mmol) and 0.5mL water, in the chirality secondary amine catalyst (0.0087g, 0.0375mmol) and phenylformic acid (0.0046g, 0.0375mmol) common catalysis following 40 ℃ the reaction 3h, (2 * 20mL), standing demix is got after organic layer distillation takes off most extraction solvent with ethyl acetate extraction, residuum is that 7: 3 elutriant is an eluent with the volume ratio of sherwood oil and ether, carry out the column chromatography for separation purification and obtain target compound (the Ee value is 75% for 0.147g, yield 80%).
Embodiment 8:(1S, 4S, 5S, 6R) preparation of 6-phenyl-5-nitro two ring [2,2,2] octane-2-ketone
25mL in vitro adds phenyl nitroolefin (0.112g, 0.75mmol), cyclonene (0.192g, 2mmol) with 0.4mL water, at chirality secondary amine catalyst (V) (0.0436g, 0.225mmol) and parafluorobenzoic acid (0.0315g, 0.225mmol) common catalysis under-20 ℃ the reaction 72h, with ethyl acetate extraction (2 * 20mL), standing demix, get after organic layer distillation takes off most extraction solvent, residuum is that 7: 3 elutriant is an eluent with the volume ratio of sherwood oil and ether, carries out column chromatography for separation and purifies and obtain target compound (0.180g, yield 98%, Ee value are 93%).
Embodiment 9:(1S, 4S, 5S, 6R) preparation of 6-phenyl-5-nitro two ring [2,2,2] octane-2-ketone
25mL in vitro adds phenyl nitroolefin (0.112g, 0.75mmol), cyclonene (0.096g, 1mmol) with 0.5mL water, at chirality secondary amine catalyst (V) (0.029g, 0.15mmol) and p-nitrobenzoic acid (0.025g, 0.15mmol) common catalysis following 25 ℃ the reaction 30h, with ethyl acetate extraction (2 * 20mL), standing demix, get after organic layer distillation takes off most extraction solvent, residuum is that 7: 3 elutriant is an eluent with the volume ratio of sherwood oil and ether, carries out column chromatography for separation and purifies and obtain target compound (0.180g, yield 98%, Ee value are 90%).
Embodiment 10:(1S, 4S, 5S, 6R) preparation of 6-phenyl-5-nitro two ring [2,2,2] octane-2-ketone
25mL in vitro adds phenyl nitroolefin (0.112g, 0.75mmol), cyclonene (0.096g, 1mmol) with 0.5mL water, at chirality secondary amine catalyst (V) (0.029g, 0.15mmol) and o-trifluoromethyl phenylformic acid (0.0285g, 0.15mmol) common catalysis following 25 ℃ the reaction 30h, with ethyl acetate extraction (2 * 20mL), standing demix, get after organic layer distillation takes off most extraction solvent, residuum is that 7: 3 elutriant is an eluent with the volume ratio of sherwood oil and ether, carries out column chromatography for separation and purifies and obtain target compound (0.180g, yield 98%, Ee value are 89%).
Embodiment 11:(1S, 4S, 5S, 6R) preparation of 6-(the fluorine-based phenyl of 4-)-5-nitro two ring [2,2,2] octane-2-ketone
25mL in vitro adds 4-fluorophenyl nitroolefin (0.125g, 0.75mmol), cyclonene (0.096g, 1mmol) with 0.5mL water, at chirality secondary amine catalyst (V) (0.029g, 0.15mmol) and to trifluoromethylbenzoic acid (VI) (0.0285g, 0.15mmol) common catalysis following 25 ℃ the reaction 20h, with ethyl acetate extraction (2 * 20mL), standing demix is got after organic layer distillation takes off most solvent, and residuum is that 7: 3 elutriant is an eluent with the volume ratio of sherwood oil and ether, carry out the column chromatography for separation purification and obtain target compound (0.191g, yield 97%, Ee value are 95%), wherein 1H NMR (500MHz, CDCl3): δ=7.09-7.06 (m, 2H), 7.02-6.99 (m, 2H), and 4.76-4.73 (m, 1H), 4.14-4.12 (m, 1H), and 2.98-2.97 (m, 1H), 2.66-2.65 (m, 1H), and 2.52-2.48 (m, 2H), 2.24-2.18 (m, 1H), 1.98-1.93 (m, 2H), 1.76-1.70 (m, 1H) ppm; 13C NMR (125MHz, CDCl3): δ=211.7,162.0 (d, 1J C-F=245.8Hz), and 136.9,128.6,128.5,116.2,116.0,91.3,47.6,44.3,42.3,34.3,23.3,18.1ppm.
Embodiment 12:(1S, 4S, 5S, 6R) preparation of 6-(4-chloro phenyl)-5-nitro two ring [2,2,2] octane-2-ketone
25mL in vitro adds 4-chloro-phenyl-nitroolefin (0.137g, 0.75mmol), cyclonene (0.096g, 1mmol) with 0.5mL water, at chirality secondary amine catalyst (V) (0.029g, 0.15mmol) and to trifluoromethylbenzoic acid (VI) (0.0285g, 0.15mmol) common catalysis following 25 ℃ the reaction 20h, with ethyl acetate extraction (2 * 20mL), standing demix is got after organic layer distillation takes off most solvent, and residuum is that 7: 3 elutriant is an eluent with the volume ratio of sherwood oil and ether, carry out the column chromatography for separation purification and obtain target compound (0.207g, yield 99%, Ee value are 94%), wherein 1H NMR (500MHz, CDCl3): δ=7.30-7.28 (d, J=7.5Hz, 2H), 7.05-7.04 (d, J=7.5Hz, 2H), 4.73-4.72 (m, 1H), and 4.13-4.11 (m, 1H), 3.03-2.96 (m, 1H), and 2.66-2.65 (m, 1H), 2.55-2.44 (m, 2H), and 2.24-2.18 (m, 1H), 1.99-1.89 (m, 2H), 1.75-1.69 (m, 1H) ppm; 13C NMR (125MHz, CDCl3): δ=211.5,139.5,133.7,129.4 (* 2), 128.2 (* 2), 91.0,47.4,44.4,42.3,34.3,23.2,18.1ppm.
Embodiment 13:(1S, 4S, 5S, 6R) preparation of 6-(3-bromo phenyl)-5-nitro two ring [2,2,2] octane-2-ketone
25mL in vitro adds 3-bromophenyl nitroolefin (0.170g, 0.75mmol), cyclonene (0.096g, 1mmol) with 0.5mL water, at chirality secondary amine catalyst (V) (0.029g, 0.15mmol) and to trifluoromethylbenzoic acid (VI) (0.0285g, 0.15mmol) common catalysis following 25 ℃ the reaction 12h, with ethyl acetate extraction (2 * 20mL), standing demix is got after organic layer distillation takes off most solvent, and residuum is that 7: 3 elutriant is an eluent with the volume ratio of sherwood oil and ether, carry out the column chromatography for separation purification and obtain target compound (0.133g, yield 55%, Ee value are 88%), wherein 1H NMR (500MHz, CDCl3): δ=7.41-7.40 (m, 1H), 7.27-7.26 (m, 1H), 7.21-7.18 (m, 1H), 7.03-7.02 (m, 1H), 4.77-4.75 (m, 1H), 4.13-4.12 (m, 1H), 3.00-2.99 (m, 1H), 2.67-2.65 (m, 1H), 2.52-2.50 (m, 2H), 2.21-2.18 (m, 1H), 1.98-1.90 (m, 2H), 1.76-1.70 (m, 1H) ppm; 13C NMR (125MHz, CDCl3): δ=211.2,143.2,130.9,130.8,130.2,125.3,123.2,90.7,47.3,44.6,42.2,34.2,23.2,18.1ppm.
Embodiment 14:(1S, 4S, 5S, 6R) preparation of 6-(4-bromo phenyl)-5-nitro two ring [2,2,2] octane-2-ketone
25mL in vitro adds 4-bromophenyl nitroolefin (0.170g, 0.75mmol), cyclonene (0.096g, 1mmol) with 0.5mL water, at chirality secondary amine catalyst (V) (0.029g, 0.15mmol) and to trifluoromethylbenzoic acid (VI) (0.0285g, 0.15mmol) common catalysis following 25 ℃ the reaction 12h, with ethyl acetate extraction (2 * 20mL), standing demix is got after organic layer distillation takes off most solvent, and residuum is that 7: 3 elutriant is an eluent with the volume ratio of sherwood oil and ether, carry out the column chromatography for separation purification and obtain target compound (0.222g, yield 92%, Ee value are 92%), wherein 1H NMR (500MHz, CDCl3): δ=7.45-7.43 (d, J=10Hz, 2H), 7.00-6.98 (d, J=10Hz, 2H), 4.73-4.71 (m, 1H), and 4.12-4.10 (m, 1H), 2.99-2.97 (m, 1H), and 2.66-2.64 (m, 1H), 2.55-2.43 (m, 2H), and 2.24-2.17 (m, 1H), 1.96-1.92 (m, 2H), 1.75-1.70 (m, 1H) ppm; 13C NMR (125MHz, CDCl3): δ=211.5,140.0,132.3 (* 2), 128.6 (* 2), 121.8,90.9,47.4,44.5,42.3,34.3,23.2,18.1ppm.
Embodiment 15:(1S, 4S, 5S, 6R) preparation of 6-(3-nitrophenyl)-5-nitro two ring [2,2,2] octane-2-ketone
25mL in vitro adds 3-nitrophenyl nitroolefin (0.146g, 0.75mmol), cyclonene (0.096g, 1mmol) with 0.5mL water, at chirality secondary amine catalyst (V) (0.029g, 0.15mmol) and to trifluoromethylbenzoic acid (VI) (0.0285g, 0.15mmol) common catalysis following 25 ℃ the reaction 12h, with ethyl acetate extraction (2 * 20mL), standing demix is got after organic layer distillation takes off most solvent, and residuum is that 7: 3 elutriant is an eluent with the volume ratio of sherwood oil and ether, carry out the column chromatography for separation purification and obtain target compound (0.152g, yield 70%, Ee value are 93%), wherein 1H NMR (500MHz, CDCl3): δ=8.51-8.50 (m, 1H), 8.32-8.30 (m, 1H), and 7.95-7.94 (m, 1H), 7.69-7.66 (m, 1H), and 3.72-3.69 (m, 1H), 3.64-3.63 (m, 1H), and 2.67-2.63 (m, 2H), 2.51-2.47 (m, 1H), and 2.36-2.31 (m, 1H), 1.90-1.83 (m, 2H), 1.75-1.69 (m, 2H) ppm; 13C NMR (125MHz, CDCl3): δ=211.0,149.6,139.9,132.8,130.3,124.6,122.0,93.0,41.6,40.1,35.7,34.6,21.7,20.3ppm.
Embodiment 16:(1S, 4S, 5S, 6R) preparation of 6-(4-trifluoromethyl)-5-nitro two ring [2,2,2] octane-2-ketone
25mL in vitro adds 4-trifluoromethyl nitroolefin (0.163g, 0.75mmol), cyclonene (0.096g, 1mmol) with 0.5mL water, at chirality secondary amine catalyst (V) (0.029g, 0.15mmol) and to trifluoromethylbenzoic acid (VI) (0.0285g, 0.15mmol) common catalysis following 25 ℃ the reaction 12h, with ethyl acetate extraction (2 * 20mL), standing demix is got after organic layer distillation takes off most solvent, and residuum is that 7: 3 elutriant is an eluent with the volume ratio of sherwood oil and ether, carry out the column chromatography for separation purification and obtain target compound (0.230g, yield 98%, Ee value are 90%), wherein 1HNMR (500MHz, CDCl3): δ=7.65-7.55 (m, 2H), 7.26-7.20 (m, 2H), and 4.79-4.75 (m, 1H), 4.23-4.22 (m, 1H), and 3.03-3.00 (m, 1H), 2.72-2.68 (m, 1H), and 2.59-2.46 (m, 2H), 2.27-2.18 (m, 1H), 1.99-1.94 (m, 2H), 1.77-1.75 (m, 1H) ppm; 13C NMR (125MHz, CDCl3): δ=211.4,144.9,130.5,128.5,127.4 (* 2), 126.2 (* 2), 90.6,47.2,44.7,42.2,34.2,23.1,18.1ppm.
Embodiment 17:(1S, 4S, 5S, 6R) preparation of 6-furans-5-nitro two ring [2,2,2] octane-2-ketone
25mL in vitro adds furans nitroolefin (0.104g, 0.75mmol), cyclonene (0.096g, 1mmol) with 0.5mL water, at chirality secondary amine catalyst (V) (0.029g, 0.15mmol) and to trifluoromethylbenzoic acid (VI) (0.0285g, 0.15mmol) common catalysis following 25 ℃ the reaction 20h, with ethyl acetate extraction (2 * 20mL), standing demix is got after organic layer distillation takes off most solvent, and residuum is that 7: 3 elutriant is an eluent with the volume ratio of sherwood oil and ether, carry out the column chromatography for separation purification and obtain target compound (0.169g, yield 96%, Ee value are 92%), wherein 1H NMR (500MHz, CDCl3): δ=7.32-7.31 (d, J=5Hz, 1H), 6.28-6.27 (m, 1H), and 6.13-6.12 (d, J=5Hz, 1H), 4.94-4.92 (m, 1H), 4.28-4.26 (m, 1H), 3.00-2.96 (m, 1H), 2.70-2.69 (m, 1H), 2.48-2.45 (m, 2H), 2.20-2.13 (m, 1H), 2.01-1.94 (m, 2H), 1.70-1.63 (m, 1H) ppm; 13C NMR (125MHz, CDCl3): δ=210.7,152.9,142.7,110.4,106.6,87.7,46.0,41.8,38.8,34.3,22.4,18.4ppm.
Embodiment 18:(1S, 4S, 5S, 6R) preparation of 6-phenyl-4-methyl-5-nitro two ring [2,2,2] octane-2-ketone
25mL in vitro adds phenyl nitroolefin (0.112g, 0.75mmol), 3-methyl cyclohexane ketenes (0.220g, 2mmol) with 0.5mL water, at chirality secondary amine catalyst (V) (0.048g, 0.25mmol) and to trifluoromethylbenzoic acid (VI) (0.0475g, 0.25mmol) common catalysis following 30 ℃ the reaction 20h, with ethyl acetate extraction (2 * 20mL), standing demix is got after organic layer distillation takes off most solvent, and residuum is that 7: 3 elutriant is an eluent with the volume ratio of sherwood oil and ether, carry out the column chromatography for separation purification and obtain target compound (0.184g, yield 95%, Ee value are 83%), wherein 1H NMR (500MHz, CDCl3): 7.32-7.25 (m, 3H), 7.06-7.05 (d, J=5Hz, 2H), and 4.69-4.68 (d, J=5Hz, 1H), 3.96-3.95 (d, J=5Hz, 1H), 2.74-2.73 (d, J=5Hz, 1H), 2.38-2.30 (m, 2H), 2.26-2.18 (m, 2H), 2.01-1.93 (m, 1H), 1.51-1.42 (m, 1H), 1.09 (s, 3H) ppm; 13CNMR (125MHz, CDCl3): δ=211.9,140.8,129.3 (* 2), 127.8,126.6 (* 2), 96.9,49.5,47.5,46.9,37.7,24.8,24.1,23.1ppm.
Embodiment 19:(1S, 2R, 3S, 4R) 2-phenyl-5, the preparation of 5-dimethyl-3-nitro two ring [2,2,2] octane-7-ketones
25mL in vitro adds phenyl nitroolefin (0.112g, 0.75mmol), 4,4-dimethyl cyclonene (0.248g, 2mmol) with 0.5mL water, at chirality secondary amine catalyst (V) (0.039g, 0.20mmol) and to trifluoromethylbenzoic acid (VI) (0.038g, 0.20mmol) common catalysis following 15 ℃ the reaction 20h, with ethyl acetate extraction (2 * 20mL), standing demix, get after organic layer distillation takes off most solvent, residuum is that 7: 3 elutriant is an eluent with the volume ratio of sherwood oil and ether, carries out column chromatography for separation and purifies and obtain target compound (0.196g, yield 96%, the Ee value is 93%), wherein 1HNMR (500MHz, CDCl3): δ=7.33-7.24 (m, 3H), 7.17-7.15 (d, J=10Hz, 2H), and 4.60-4.58 (d, J=10Hz, 1H), 4.22-4.20 (d, J=10Hz, 1H), 2.97 (s, 1H), 2.88-2.84 (m, 1H), 2.61 (s, 1H), 2.37-2.33 (m, 1H), 2.02-1.99 (m, 1H), 1.76-1.73 (m, 1H), 1.13 (s, 3H), 1.12 (s, 3H) ppm; 13C NMR (125MHz, CDCl3): δ=211.9,141.3,129.1 (* 2), 127.6 (* 2), 127.2,90.1,51.0,44.3,43.2,40.9,40.3,30.9,30.6,29.5ppm.

Claims (10)

1. green method of asymmetric synthesis suc as formula the chiral bicyclics compound shown in (I), it is characterized in that described method is: being raw material suc as formula the cyclohexenone derivates shown in (II) with suc as formula the nitroolefin derivative shown in (III), in the presence of chirality secondary amine catalyst, protonic acid and water, under-20~40 ℃ of temperature, reacted 3~72 hours, after reaction finished, the reaction solution separating treatment obtained suc as formula the chiral bicyclics compound shown in (I); Described chirality secondary amine catalyst is suc as formula the proline derivative shown in (IV); Described is 1: 1~3 suc as formula the nitroolefin derivative shown in (III) with suc as formula the amount of substance ratio of the cyclohexenone derivates shown in (II); Described amount of substance ratio suc as formula the nitroolefin derivative shown in (III), chirality secondary amine catalyst, protonic acid, water is 1: 0-05~0-3: 0-05~0-3: 30~40;
In formula (I), formula (II), formula (III) or the formula (IV), R 1, R 2, R 3Independent separately is the alkyl of H or C1~C20; R 4Be H, the alkyl of C1~C20, the 2-p-methoxy-phenyl, the 3-p-methoxy-phenyl, the 4-p-methoxy-phenyl, the 2-aminomethyl phenyl, the 3-aminomethyl phenyl, the 4-aminomethyl phenyl, phenyl, the fluorine-based phenyl of 2-, the fluorine-based phenyl of 3-, the fluorine-based phenyl of 4-, 2-chloro phenyl, 3-chloro phenyl, 4-chloro phenyl, 2-bromo phenyl, 3-bromo phenyl, 4-bromo phenyl, the 2-nitrophenyl, the 3-nitrophenyl, the 4-nitrophenyl, the 2-trifluoromethyl, the 3-trifluoromethyl, the 4-trifluoromethyl, furyl or thienyl; R 5Be one of following formula:
Figure A2009100975150003C1
2. the green method of asymmetric synthesis of chiral bicyclics compound as claimed in claim 1 is characterized in that described R 1, R 2, R 3Independent separately is hydrogen or methyl.
3. the green method of asymmetric synthesis of chiral bicyclics compound as claimed in claim 1 is characterized in that described R 4Be 2-p-methoxy-phenyl, 3-p-methoxy-phenyl, 4-p-methoxy-phenyl, 4-aminomethyl phenyl, phenyl, the fluorine-based phenyl of 4-, 4-chloro phenyl, 3-bromo phenyl, 4-bromo phenyl, 3-nitrophenyl, 4-trifluoromethyl or furyl.
4. as the green method of asymmetric synthesis of the described chiral bicyclics compound of one of claim 1~3, it is characterized in that described chirality secondary amine catalyst is shown in formula V;
Figure A2009100975150003C2
5. the green method of asymmetric synthesis of chiral bicyclics compound as claimed in claim 1 is characterized in that described protonic acid is one of following: HCl, HBr, H 28O 4, HBF 4, HPF 6, CH3COOH, CF 3COOH, CF 3SO 3H, phenylformic acid, o-fluorobenzoic acid, a fluorobenzoic acid, parafluorobenzoic acid, toluylic acid, p-methylbenzoic acid, o-Carboxynitrobenzene, M-NITROBENZOIC ACID, p-nitrobenzoic acid, o-trifluoromethyl phenylformic acid, m-trifluoromethylbenzoic acid, to trifluoromethylbenzoic acid, Phenylsulfonic acid, p-methyl benzenesulfonic acid, to Witco 1298 Soft Acid, α-Nai Huangsuan, beta-naphthalenesulfonic-acid, α-Nai Yisuan, oleic acid, stearic acid, dodecyl sulfonic acid or methacrylic acid.
6. the green method of asymmetric synthesis of chiral bicyclics compound as claimed in claim 1 is characterized in that described protonic acid is organic protonic acid.
7. the green method of asymmetric synthesis of chiral bicyclics compound as claimed in claim 6 is characterized in that described organic protonic acid is one of following: phenylformic acid, parafluorobenzoic acid, p-nitrobenzoic acid, o-trifluoromethyl phenylformic acid or to trifluoromethylbenzoic acid.
8. the green method of asymmetric synthesis of chiral bicyclics compound as claimed in claim 1 is characterized in that described amount of substance ratio suc as formula the nitroolefin derivative shown in (III), chirality secondary amine catalyst, protonic acid, water is 1: 0.2: 0.2: 34.
9. the green method of asymmetric synthesis of chiral bicyclics compound as claimed in claim 1 is characterized in that described temperature of reaction is 25 ℃, and the reaction times is 12~36 hours.
10. the green method of asymmetric synthesis of chiral bicyclics compound as claimed in claim 1, it is characterized in that described reaction solution method for separating and processing is: after reaction finishes, the reaction solution ethyl acetate extraction, standing demix, get the organic layer distillation except that the residuum after desolvating, with the volume ratio of sherwood oil and ether is that 7: 3 elutriant is an eluent, carries out column chromatography for separation and purifies and obtain the chiral bicyclics compound product.
CN 200910097515 2009-04-03 2009-04-03 Green asymmetric synthesis method of chiral bicyclics compound Expired - Fee Related CN101525291B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200910097515 CN101525291B (en) 2009-04-03 2009-04-03 Green asymmetric synthesis method of chiral bicyclics compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200910097515 CN101525291B (en) 2009-04-03 2009-04-03 Green asymmetric synthesis method of chiral bicyclics compound

Publications (2)

Publication Number Publication Date
CN101525291A true CN101525291A (en) 2009-09-09
CN101525291B CN101525291B (en) 2012-12-12

Family

ID=41093390

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200910097515 Expired - Fee Related CN101525291B (en) 2009-04-03 2009-04-03 Green asymmetric synthesis method of chiral bicyclics compound

Country Status (1)

Country Link
CN (1) CN101525291B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102531911A (en) * 2011-12-22 2012-07-04 浙江工业大学 Chiral dicyclic compound and asymmetric syntheses method thereof
CN114426323A (en) * 2020-09-21 2022-05-03 中国石油化工股份有限公司 Oil field polymer bactericidal flocculant and preparation method and application thereof
CN116024083A (en) * 2023-02-22 2023-04-28 凯莱英生命科学技术(天津)有限公司 Device and method for preparing chiral amine compound by continuous flow reaction

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101041638B (en) * 2007-04-29 2010-05-26 浙江工业大学 Chirality amine containing imidazole sulfur ether structure and preparation method and usage thereof

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102531911A (en) * 2011-12-22 2012-07-04 浙江工业大学 Chiral dicyclic compound and asymmetric syntheses method thereof
CN102531911B (en) * 2011-12-22 2016-02-17 浙江工业大学 Chiral bicyclics compound and method of asymmetric synthesis thereof
CN114426323A (en) * 2020-09-21 2022-05-03 中国石油化工股份有限公司 Oil field polymer bactericidal flocculant and preparation method and application thereof
CN114426323B (en) * 2020-09-21 2022-11-04 中国石油化工股份有限公司 Oil field polymer sterilization flocculant and preparation method and application thereof
CN116024083A (en) * 2023-02-22 2023-04-28 凯莱英生命科学技术(天津)有限公司 Device and method for preparing chiral amine compound by continuous flow reaction
CN116024083B (en) * 2023-02-22 2023-06-13 凯莱英生命科学技术(天津)有限公司 Device and method for preparing chiral amine compound by continuous flow reaction

Also Published As

Publication number Publication date
CN101525291B (en) 2012-12-12

Similar Documents

Publication Publication Date Title
KR101099408B1 (en) Subsidiary urea compound and subsidiary conjugated addition using the catalyst as a method for producing a subsidiary compound by reaction
CN104447725A (en) Chiral compound comprising iminopyridyl oxazoline and preparation method thereof
CN101525291B (en) Green asymmetric synthesis method of chiral bicyclics compound
CN104447451A (en) New preparation method of oseltamivir intermediate
KR102261108B1 (en) Highly enantioselective bifunctional chiral organocatalytic compound, method for preparing the same, and method for preparing non-natural gamma-amino acid from nitrocompound using thereof
CN101781222A (en) Method for preparing enamine ketone compound
Das et al. Sulfonic acid functionalized silica: an efficient heterogeneous catalyst for a three-component synthesis of 1, 4-dihydropyridines under solvent-free conditions
CN102906064A (en) Method for producing (1r, 2s)-1-amino-2-vinyl cyclopropane carboxylic acid ester that has improved optical purity
CN112812033B (en) Novel synthesis method of oseltamivir
CN110698426B (en) Method for preparing 1, 3-benzothiazole derivative by efficient catalysis of potassium tert-butoxide
CN101845011B (en) (S)-prolineamide type derivative, preparation method and application thereof
CN102140071A (en) Method for synthesizing 2-(4-tert-butyl-phenyl) malonic mononitrile (2-methoxyl) ethyl ester
CN105481715A (en) Camphor Schiff base, and preparation method and application thereof
CN102627571B (en) Preparation and synthesis method for chiral ammonium salt
CN102060754A (en) Method for preparing polysubstituted tetrahydropyridine
CN101372458A (en) Method for synthesizing acylated enamine without catalyst or solvent
CN109575041B (en) Polycyclic pyridine compound and preparation method thereof
CN111018771B (en) Method for synthesizing 3- (2-cyanovinyl) indole derivative
CN101863815A (en) Synthesis method of cis 3-phenyl substituted s-proline derivative
JP5179430B2 (en) Method for producing optically active alcohol
KR100616276B1 (en) Process for producing 2,n-dimethyl-n-(3,3-diphenylpropyl)-1-amino-2-propanol
CN112824411A (en) Bridged ring isoindolinone derivatives, and preparation method and application thereof
CN101863805B (en) (S)-N-(2(3-(trifluoromethyl) phenyl) methyl)-tertiary butyl-2-sulfinamide and synthesis method thereof
Shen et al. An efficient synthesis of enantiomerically pure trans-N1, N2-dimethylcyclohexane-1, 2-diamine
CN113861072A (en) Preparation method of aryl cyclopropane compound

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20121212